Owens & Minor, Inc. (NYSE:OMI) Stock Holdings Cut by Phocas Financial Corp.

Phocas Financial Corp. reduced its position in shares of Owens & Minor, Inc. (NYSE:OMI) by 85.0% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 32,601 shares of the company’s stock after selling 184,363 shares during the quarter. Phocas Financial Corp.’s holdings in Owens & Minor were worth $426,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Blue Trust Inc. boosted its stake in Owens & Minor by 57.4% during the 4th quarter. Blue Trust Inc. now owns 4,387 shares of the company’s stock valued at $57,000 after purchasing an additional 1,600 shares in the last quarter. KBC Group NV boosted its stake in Owens & Minor by 98.2% during the 4th quarter. KBC Group NV now owns 4,434 shares of the company’s stock valued at $58,000 after purchasing an additional 2,197 shares in the last quarter. Segall Bryant & Hamill LLC boosted its stake in Owens & Minor by 2.1% during the 3rd quarter. Segall Bryant & Hamill LLC now owns 137,199 shares of the company’s stock valued at $2,153,000 after purchasing an additional 2,883 shares in the last quarter. Linden Thomas Advisory Services LLC boosted its stake in Owens & Minor by 16.3% during the 4th quarter. Linden Thomas Advisory Services LLC now owns 26,302 shares of the company’s stock valued at $344,000 after purchasing an additional 3,688 shares in the last quarter. Finally, Franklin Resources Inc. boosted its stake in shares of Owens & Minor by 6.5% during the 3rd quarter. Franklin Resources Inc. now owns 61,223 shares of the company’s stock worth $961,000 after acquiring an additional 3,743 shares in the last quarter. 98.04% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

OMI has been the subject of several research reports. Barclays reduced their price objective on Owens & Minor from $18.00 to $14.00 and set an “equal weight” rating for the company in a research note on Tuesday, November 5th. Citigroup reduced their price objective on Owens & Minor from $21.00 to $18.50 and set a “buy” rating for the company in a research note on Tuesday, November 5th. UBS Group reduced their price objective on Owens & Minor from $25.00 to $13.00 and set a “buy” rating for the company in a research note on Thursday, February 13th. Finally, Robert W. Baird reduced their price objective on Owens & Minor from $14.00 to $10.00 and set a “neutral” rating for the company in a research note on Tuesday. Two equities research analysts have rated the stock with a sell rating, three have given a hold rating and two have given a buy rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average price target of $14.92.

Owens & Minor Stock Performance

Shares of Owens & Minor stock opened at $6.84 on Thursday. The stock has a market cap of $527.04 million, a PE ratio of -10.52, a price-to-earnings-growth ratio of 0.20 and a beta of 0.48. The business has a fifty day simple moving average of $11.68 and a 200-day simple moving average of $13.35. The company has a quick ratio of 0.45, a current ratio of 1.09 and a debt-to-equity ratio of 2.11. Owens & Minor, Inc. has a 12 month low of $6.07 and a 12 month high of $28.35.

Owens & Minor Company Profile

Owens & Minor, Inc is a healthcare solutions company, which engages in the product manufacturing and delivery, home health supply, and perioperative services to support care through the hospital and into the home. It operates through the Products and Healthcare Services, and Patient Direct segments.